eClinical Solutions Market Worth 9,756 Mn USD by 2026
The global eClinical Solutions market size is anticipated to around USD 9,756 million by 2026, this market is anticipated to grow with 9.7% CAGR during the forecast time period. In the eClinical Solutions market, The regional segmentation includes current and projected demand in North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.
North America held the maximum share of the global eClinical solutions market in 2018 and is also anticipated to observe its dominance during the forecast period. North America consists of the U.S. and Canada. Both countries have high admeoption of innovative software solutions for clinical research. Furthermore, high government funding to support clinical trials, local presence of prominent players, presence of sophisticated infrastructure, and increasing prevalence of chronic diseases such as diabetes and cardiac disorders are some of the other factors that contributed to the dominance of the region in 2018.
Get Free Report Sample Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1637
However, Asia Pacific is witnessing the fastest growth during the forecast period. This can be attributed to increasing outsourcing number of trials to countries such as India, China, Korea, and Japan due to the low cost and presence of a large patient population. Thereby, this outsourcing boosted the adoption of eClinical solutions in these regions. Presence of emerging economies, government funding for the research & development, and investment by multinational players are expected to propel the market growth during the forecast period.
Based on the product the market has been segmented into ECOA, EDC & CDMS, Clinical Analytics Platforms, Clinical data integration platforms, Safety solutions, CTMS, RTSM, and eTMF. The electronic data capture (EDC) and clinical data management system (CDMS) accounted for the maximum share of the eClinical solutions market in 2018. However, the electronic clinical outcome assessment (eCOA) is anticipated to observe the fastestgrowth during the forecast period.This can be attributed to the increasing importance of high-quality clinical data. Collecting data by using eCOA platforms enhance the quality of derived information, streamline data collection procedures, and offers effective data analysis.
View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/eclinical-solutions-market
eClinical Solutions Market (By Product: Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems; By Delivery Mode: Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premise) Solutions, Cloud-Based (SaaS) Solutions; By Clinical Trial Phase: Phase I Clinical Trials, Phase II Clinical Trials; By End-Use: Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026
Based on the delivery mode, eClinical solutions market is divided into the web-hosted, licensed enterprise (on-premise), and cloud-based mode. The web-hosted segment dominated the market in 2018 and is expected to maintain its dominance during the forecast period. This can be attributed to benefits associated with a delivery mode such as lower investment, easily customizable, a greater level of interoperability, and easy accessibility. The cloud-based system is anticipated to drive the market at the fastest rate in the coming years. Easy data backup and availability of real-time data are some of the advantages of a cloud-based system.
Based on the development phase of the clinical trial, phase III segment accounted for the largest share of the market in 2018. The complexity of the phase increases with an increase in the number of patients, which enhance the demand for computer-based solutions for clinical data management, thereby the adoption of eClinical solutions for phase III clinical trial is more.
Key players operating in the eclinical solutions market are IBM Watson Health; Oracle Corporation; Medidata Solutions Inc.; Cinven; DATATRAK International, Inc.; PAREXEL International Corporation; CRF Bracket; ERT; eClinical Solutions; and OmniComm Systems Inc. Partnerships or collaboration between technology and CRO, pharmaceutical or biopharmaceutical companies and acquisitions are the key strategies being adopted by the market players to accelerate their growth in recent years.
Some of the key observations regarding the eClinical solutions market include:
- In June 2019, DassaultSystemes, a France based software company acquired Medidata Solutionsto expand its client base in the life-science industry. Medidata's market experience in clinical trials complements the company's life sciences solutions on the 3DEXPERIENCE collaborative platform.
- In May 2019, Great Point Partners, an equity firm, invested in Axiomto increase service offerings for phase I to Phase III clinical trials. Axiom is a Toronto based growing firm specializes in data management, electronic data capture, electronic patient-reported outcomes, and clinical trial management systems for pharmaceutical and biotechnology clinical trial sponsors, invested in growing eClinical solution company.
- In September 2018, Genster merged its clinical research tech companies CRF Health and Bracket. The newly formed company named a CRF Bracket. Combining the experience of both the teams in clinical trial technology is expected to help in accelerative innovation, maintaining focus on expert service, and scaling a powerful business.
- In July 2018, OmniComm Systems, Inc., a global provider of clinical data management technology, launched its new subsidiary called OmniCommeClinical Solutions Pvt. Ltd. and established its office in Bengaluru, India to expand international presence. Launch of the new subsidiary was a result of the company's acquisition of the Acuity advanced clinical analytics platform from Algorics.
- In October 2016, Cinven acquired Bioclinica to enter in the clinical trial sector. Bioclinica provides clinical trial services and technology to pharmaceutical companies and CROs.
Market Segmentation
Market by Product
- Electronic Data Capture and Clinical Data Management Systems
- Clinical Trial Management Systems
- Clinical Analytics Platforms
- Randomization and Trial Supply Management
- Clinical Data Integration Platforms
- Electronic Clinical Outcome Assessment Solutions
- Safety Solutions
- Electronic Trial Master File Systems
- Regulatory Information Management Solutions
- Others
Market by Delivery Mode
- Web-Hosted (On-Demand) Solutions
- Licensed Enterprise (On-Premise) Solutions
- Cloud-Based (SaaS) Solutions
Market by Clinical Trial Phase
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV Clinical Trials
Market by End-use
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organizations
- Consulting Service Companies
- Medical Device Manufacturers
- Hospitals
- Academic Research Institutes
Market By Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Key Questions Answered in the Report
The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-
- What is the overall structure of the market?
- What was the historical value and what is the forecasted value of the market?
- What are the key product level trends in the market?
- What are the market level trends in the market?
- Which of the market players are leading and what are their key differential strategies to retain their stronghold?
- Which are the most lucrative regions in the market space?
Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1637
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of eClinical Solutions
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. eClinical Solutions Market By Product
1.2.2.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global eClinical Solutions Market Revenue Share By Product in 2018
1.2.2.3. Electronic Data Capture and Clinical Data Management Systems
1.2.2.4. Clinical Trial Management Systems
1.2.2.5. Clinical Analytics Platforms
1.2.2.6. Randomization and Trial Supply Management
1.2.2.7. Clinical Data Integration Platforms
1.2.2.8. Electronic Clinical Outcome Assessment Solutions
1.2.2.9. Safety Solutions
1.2.2.10. Electronic Trial Master File Systems
1.2.2.11. Regulatory Information Management Solutions
1.2.2.12. Others
1.2.3. eClinical Solutions Market By Delivery Mode
1.2.3.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Delivery Mode (2015-2026)
1.2.3.2. Web-Hosted (On-Demand) Solutions
1.2.3.3. Licensed Enterprise (On-Premise) Solutions
1.2.3.4. Cloud-Based (SaaS) Solutions
1.2.4. eClinical Solutions Market By Clinical Trial Phase
1.2.4.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Clinical Trial Phase (2015-2026)
1.2.4.2. Phase I Clinical Trials
1.2.4.3. Phase II Clinical Trials
1.2.4.4. Phase III Clinical Trials
1.2.4.5. Phase IV Clinical Trials
1.2.5. eClinical Solutions Market By End-use
1.2.5.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.5.2. Pharmaceutical and Biopharmaceutical Companies
1.2.5.3. Contract Research Organizations
1.2.5.4. Consulting Service Companies
1.2.5.5. Medical Device Manufacturers
1.2.5.6. Hospitals
1.2.5.7. Academic Research Institutes
1.2.6. eClinical Solutions Market By Geography
1.2.6.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.3. Europe eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.4. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.5. Latin America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.6. Middle East and Africa (MEA) eClinical Solutions Market Revenue and Growth Rate(2015-2026)
CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global eClinical Solutions Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global eClinical Solutions Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global eClinical Solutions Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global eClinical Solutions Major Manufacturers in 2018
CHAPTER 4. ECLINICAL SOLUTIONS MARKET BY PRODUCT
4.1. Global eClinical Solutions Revenue By Product
4.2. Electronic Data Capture and Clinical Data Management Systems
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Clinical Trial Management Systems
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Clinical Analytics Platforms
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Randomization and Trial Supply Management
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Clinical Data Integration Platforms
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Electronic Clinical Outcome Assessment Solutions
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Safety Solutions
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.9. Electronic Trial Master File Systems
4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.10. Regulatory Information Management Solutions
4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.11. Others
4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE
5.1. Global eClinical Solutions Revenue By Delivery Mode
5.2. Web-Hosted (On-Demand) Solutions
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Licensed Enterprise (On-Premise) Solutions
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Cloud-Based (SaaS) Solutions
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE
6.1. Global eClinical Solutions Revenue By Clinical Trial Phase
6.2. Phase I Clinical Trials
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Phase II Clinical Trials
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Phase III Clinical Trials
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Phase IV Clinical Trials
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. ECLINICAL SOLUTIONS MARKET By End-use
7.1. Global eClinical Solutions Revenue By End-use
7.2. Pharmaceutical and Biopharmaceutical Companies
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Contract Research Organizations
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Consulting Service Companies
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Medical Device Manufacturers
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6. Hospitals
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7. Academic Research Institutes
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 8. NORTH AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
8.1. North America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. eClinical Solutions Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 9. EUROPE ECLINICAL SOLUTIONS MARKET BY COUNTRY
9.1. Europe eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 10. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET BY COUNTRY
10.1. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 11. LATIN AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
11.1. Latin America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 12. MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
12.1. Middle East & Africa eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East & Africa eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Oracle Corporation
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Medidata Solutions, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Parexel International Corporation
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Bioclinica, Inc. (A Subsidiary of Cinven)
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Datatrak International, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. CRF Health
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. ERT Clinical
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Merge Healthcare Incorporated
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Omnicomm Systems, Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Maxisit Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Bio-Optronics, Inc.
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1637
If you would like to place an order or have any questions, please feel free to contact at [email protected] | +1-407-915-4157 OR +1-408-900-9135
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
Contact Us:
Phone: +14079154157 | +14089009135